As a leading CGM maker, DexCom is likely to play a significant role in diabetes care for years, possibly decades. Given all ...

DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...

These once-sizable artificial intelligence (AI) holdings for Google parent Alphabet have been paired down big-time over the ...

Today, Benzinga 's options scanner spotted 8 uncommon options trades for DexCom. This isn't normal. The overall sentiment of ...

Abbott's strong innovation pipeline, including advancements in CGM systems, supports its market share gains and growth ...

Stock indexes may have rallied higher since bottoming in August. But, some stocks have fallen behind, and are looking to ...

Eversense 365 cleared in the U.S. as an integrated continuous glucose monitoring (iCGM) system for people with diabetesWith a single sensor, the ...

We recently published a list of 16 Best Mid Cap Growth Stocks To Buy Now. In this article, we are going to take a look at ...

Detailed price information for S&P Emerging Markets Low Vol Invesco ETF (EELV-A) from The Globe and Mail including charting and trades.

Ant & Dec's Limitless Win returns for a new run, there's music documentary The Battle for Black Music: Paid in Full, week two of Strictly, and the final of Made in Korea: The K-Pop Experience . . .

Eversense 365 cleared in the U.S. as an integrated continuous glucose monitoring (iCGM) system for people with diabetes With a single sensor, the Eversense 365 system provides one year of use, versus ...